Field cancerization in mammary carcinogenesis - Implications for prevention and treatment of breast cancer.
about
Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast CancerSignatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancerCorrelation of immunoglobulin G expression and histological subtype and stage in breast cancerHypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing.Estrogen receptor β promoter methylation: a potential indicator of malignant changes in breast cancerBreast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal CarcinomasEpigenetic regulation of LSD1 during mammary carcinogenesis.Enriching the molecular definition of the airway "field of cancerization:" establishing new paradigms for the patient at risk for lung cancerTherapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review)Cancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress.Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine.Non-coding RNAs in Mammary Gland Development and Disease.Widespread telomere instability in prostatic lesions.An evolutionary perspective on field cancerization.Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy.Somatic mosaicism: on the road to cancer.Metastatic and triple-negative breast cancer: challenges and treatment optionsThe conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer
P2860
Q26738987-A489E33C-B89B-4FB2-BB10-7428DC17C963Q28389284-ED34180D-982E-4C85-91A4-6C2FCFAD10B9Q28703880-ACFBB52E-D353-4EB1-86D7-E112536041DDQ33556583-0FFF419E-4054-4958-8CB2-E0A0E7BC9C33Q36166879-2991E3C4-5243-4D92-8494-C3646F6753E1Q36582378-0EEDEEAE-EA60-4430-80C3-74A2BBDE337AQ36823916-373F9514-81F8-43A8-8C4D-11204DF0C39EQ36997510-87779AD0-38E3-46A5-961E-AC3A5269420BQ37029665-E2D7CFC4-64B1-4A97-BCC0-4ABB4A319DBDQ37265655-576BA154-6574-4AB0-9A51-FC87DB88E0FEQ37744985-B845B768-E83E-45F5-9BFF-C1892BAF3D9AQ38133084-4DFDB7CE-7C26-4B19-97E9-2C3589154471Q38667231-B46E83AE-164F-4D74-B6CA-90854C343CB0Q38881676-B9A54882-B72E-480F-842F-421CB6FC314DQ50020845-BE8AE3E1-4D85-4EF0-87F8-40B3AC911E0CQ53176639-CE09D59D-92E1-4E66-9A12-346454431113Q53209256-133B855C-7E07-4ACA-B022-E90D9FBDF6DBQ57105258-676A29DD-95DF-4337-A9F4-59FB3473A445Q58761284-E8667037-67D5-4E6B-86F7-79DCB24C07DB
P2860
Field cancerization in mammary carcinogenesis - Implications for prevention and treatment of breast cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Field cancerization in mammary ...... nd treatment of breast cancer.
@ast
Field cancerization in mammary ...... nd treatment of breast cancer.
@en
Field cancerization in mammary ...... nd treatment of breast cancer.
@nl
type
label
Field cancerization in mammary ...... nd treatment of breast cancer.
@ast
Field cancerization in mammary ...... nd treatment of breast cancer.
@en
Field cancerization in mammary ...... nd treatment of breast cancer.
@nl
prefLabel
Field cancerization in mammary ...... nd treatment of breast cancer.
@ast
Field cancerization in mammary ...... nd treatment of breast cancer.
@en
Field cancerization in mammary ...... nd treatment of breast cancer.
@nl
P1476
Field cancerization in mammary ...... nd treatment of breast cancer.
@en
P2093
Ashley G Rivenbark
William B Coleman
P304
P356
10.1016/J.YEXMP.2012.10.018
P577
2012-11-06T00:00:00Z